Clinical Trial

Gut Microbiome Pill

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety and efficacy of a 3D-printed ingestible pill designed to sample microbiota from the GI tract, focusing on the ability to collect data also from the small intestine. The study also aims to assess ease of use and transit time.
Protocol Amendment History 2 changes
critical Trial completed 2026-05-05
minor Completion moved earlier: 2027-01 -> 2026-04-20 2026-05-05
Trial Details
NCT Number NCT07243756
Lead Sponsor NYU Langone Health
Conditions Healthy
Enrollment 10 participants
Start Date 2026-01-21
Primary Completion 2026-04-20 (estimated)
Study Completion 2026-04-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-04